| INTRODUCTION
Eosinophilic oesophagitis (EoE) is a chronic inflammatory disorder of the oesophagus, which is increasingly reported in children and adults. 1, 2 This condition is considered a particular form of food allergy, in which proton pump inhibitor (PPI) therapy, topical steroids and specialised diets are effective in inducing and maintaining disease remission. [3] [4] [5] [6] [7] [8] [9] EoE has become the most common cause of dysphagia and food impaction in young adults. 10, 11 Over time, features of oesophageal remodelling develop leading to a diffusely narrow calibre oesophagus and dominant strictures which may cause persistent dysphagia and require oesophageal dilation.
Despite no impact on oesophageal inflammation, oesophageal dilation is one of the most effective options in the management of dysphagia of EoE patients with fibrostenotic features. 16 Earlier reports on performing dilation in patients with EoE described a higher than expected rate of complications, making dilation a less attractive approach in EoE. [17] [18] [19] [20] Several more recent studies, however, have reported dilation to be a safe procedure. [21] [22] [23] In a previous meta-analysis, we found that major complications occurred in <1% of EoE patients undergoing dilation and that 75% of patients experienced clinical improvement. 16 The meta-analysis was limited to a relatively small number of studies and was restricted to an adult population. Since then, multiple centers have published data on dilation in EoE, [24] [25] [26] including recent studies on paediatric cohorts. [27] [28] [29] To expand on and update our previous publication, we performed a systematic review and meta-analysis assessing the efficacy and safety of endoscopic dilation in children and adults with EoE.
| ME TH ODS
We used PRISMA methodology for conducting this systematic review and meta-analysis. 30 This meta-analysis was registered in PROSPERO, the International Prospective Register of Systematic Reviews (CRD42016037658). There was no funding received for this review.
| Selection criteria
To be included in this review, studies needed to involve adult or 
| Data extraction
We developed a data extraction form for this study and each author agreed upon the variables a priori. All data were extracted independently and in duplicate to minimise error or bias. 
| Quality assessment
Studies were ranked according to three metrics of quality: study design, completion of follow-up, and duration of follow-up. We assigned a score of high for randomised controlled trials, moderate for cohort studies, and low for case reports and case series. For completion of follow-up, we assigned a score of high quality if more than 80% of patients had follow-up, moderate quality if between 50% and 80% had follow-up, and low if less than 50% had follow-up or if follow-up was not reported. For duration of follow-up, high quality studies reported follow-up greater than 6 months, studies that reported follow-up between 1 and 6 months were moderate in quality, and low quality was assigned if follow-up was less than 1 month. We considered a study to be of high quality overall if it scored highly on all three metrics and low quality if it scored low on any metric (Tables S1 and S2 ).
| Endpoints
The primary outcomes of this meta-analysis were to assess the safety of dilation in EoE patients by calculating the rate of complications associated with dilation and to assess clinical improvement following dilation. Our secondary outcome was to explore whether differences existed in complication rate by type of dilator [Maloney,
Savary, Through-the-scope (TTS) Balloon].
| Statistical analysis
Percentages of patients experiencing an outcome of interest were summarised with the aid of a random effects model for proportions (STATA command metaprop one). 31 The STATA command metaprop one was used to model outcome data. This routine provides procedures for pooling proportions in a meta-analysis and displays the results in a forest plot. The pooled estimate is obtained as a weighted average by fitting the logistic-normal random-effects model without covariates but random intercepts after Freeman-Tukey Double Arcsine Transformation to stabilise the variances. 32 The confidence intervals were based on the exact binomial (Clopper-Pearson)
procedure. 33 For sparse event data, breakdown of the modelling procedure is known to occur, in which case calculation of the pooled estimate and confidence interval using the exact binomial method was performed. Statistical significance of heterogeneity was tested by means of the Chi-squared statistic for the likelihood ratio test.
Heterogeneity was also quantified using the I-squared measure assigning categories of low, moderate, high or very high for values of 1%-25%, 26%-50%, 51%-75% and 76%-100% respectively. 34 Because methods for assessing publication bias in meta-analytic studies of proportion data are not well-established, we do not present such an analysis. 35, 36 A sensitivity analysis was performed with regard to quality by excluding all case series and case reports.
All analyses were carried out using STATA (version-13.1; Statcorp, College Station, TX, USA). There was no funding received for this meta-analysis and all authors approved the final version of the manuscript.
| RESULTS
After removal of 989 duplicates, a total of 3495 potential articles were identified. Of these studies, 3435 number were excluded by title and abstract review. The full text of the remaining 60 articles was retrieved and reviewed, upon which it was determined that 27 studies met inclusion criteria ( Figure 1 ).
Of these 27 studies, one was a randomised controlled trial, 25 two were prospective cohorts, 37, 38 16 were retrospective cohort studies, 17, 21, 23, 24, [26] [27] [28] [29] [39] [40] [41] [42] [43] [44] [45] [46] [47] , two were case series and six were case reports. 19, 46, [48] [49] [50] [51] [52] [53] All of the studies were single-center, except for one which included two centers. 21 Details are presented in in all these studies except for 1, in which follow-up was 53%. 40 Sensitivity analysis conducted by excluding case series or case reports did not significantly alter the results (Figure 2 ).
Complications after dilation were rare. Perforations occurred in 0.38% (7/1831) (95% CI: 0.18-0.85 I (Figure S2 ). In the Schoepfer study, chest pain was self-reported in 74%
and considered mild, but noted in only 7% of their existing medical records. 21 There was a wide variation in the definition of laceration in the studies from mucosal disruptions following dilation to deep mucosal tears and therefore a summary estimate could not be calculated. Mucosal laceration following dilation was reported in as low as 0.6% of patients 26 and up to 100% of patients. 27 Due to the low overall complications, data were insufficient to compare the frequency of major complication rates between the three major types of dilators (Maloney, Savary, TTS).
| DISCUSSION
This systematic review and meta-analysis was performed to assess the clinical efficacy and safety of dilation in EoE. Our previous metaanalysis was limited to a relatively small number of studies and strictly to an adult population. 16 Since then, several other centers have published their data on complications rates with dilation, including the first paediatric series. Patients who have undergone dilation have more than doubled and a threefold increase in endoscopic procedures has been observed since our previous meta-analysis. We demonstrated that dilation was highly effective in improving dysphagia. The frequency of major complications, which consisted of perforation, haemorrhage, hospitalisation, or death, was rare and occurred in well below 1% of patients.
Our aim was to assess the clinical efficacy of dilation in EoE and dilation was found to improve symptoms in 95% of patients. One of the earliest studies by Straumann et al. followed the natural history of 30 patients with EoE, 11 of whom were treated with dilation. 54 Clinical improvement was observed in 91% patients. Several more recent studies with a larger population of patients have also demonstrated efficacy. In the study by Runge et al. in which 164 EoE patients were dilated, 85% achieved clinical response. 24 Compared to our previous meta-analysis, the effectiveness rate has increased by 15% and importantly, heterogeneity in clinical improvement has dropped from 86% to 10%, hinting at a highly consistent effectiveness among recent studies published over the past 3 years.
Stricture formation is a consequence of long-term untreated or under treated EoE. 12 Studies have demonstrated that length of delay in diagnosis correlates with the presence of fibrostenotic features. 12, 13 Endoscopic dilation does not impact the underlying inflammation and should be combined with an anti-inflammatory therapy. Since topical steroids and diet have shown their ability to reverse fibrotic remodelling, [55] [56] [57] it is plausible to speculate whether anti-inflammatory therapies may also reverse endoscopic features like strictures and narrow calibre oesophagus. This has been recently shown in small series or case reports and should be further explored. 58, 59 Initial case reports and small studies cautioned endoscopists about dilation in that was a newly encountered cause of food impaction and strictures. 19, 20, 60 Reports of perforation surfaced, as did the dramatic appearance of mucosal shearing following dilation or passage of an endoscope. 18,61 A large number of institutional studies is now available in children and adults. These include prospective cohorts and one randomised controlled trial demonstrating safety of dilation with a complication rate comparable to dilation for other types of oesophageal strictures. 62 In our review, we only found seven cases of perforation out of a total of 1820 dilations, which were reported in three studies. One study was a retrospective design at a single institution which resulted in three perforations from 293 dilations, a second was an audit on endoscopic complications from dilations from a tertiary care center in which three perforations occurred, and the final perforation was reported in a case report of a 17-year-old woman. We excluded cases that had perforation reported by history as we wanted to ensure endoscopic dilation was the actual cause rather than spontaneous perforation from a delayed food disimpaction. 17 In our review, there was only one case of haemorrhage reported following dilation and there was not a single death reported.
F I G U R E 2 Forest plot for clinical outcomes including all studies. With inclusion of all studies, the summary effect for clinical improvement was 95%, I 2 : 10%. After excluding case report and case series, summary effect was 90%, I 2 : 32% ( Figure S1 )
The most frequent complication reported in studies exploring the safety of dilation in EoE was mucosal laceration. However, it is noteworthy that mucosal lacerations or even deeper rents are not actually complications, but rather the intended outcome of dilation and patients may not experience clinical improvement unless a tear develops. Given the variation in studies describing this feature, we
were not able to calculate a summary effect. In addition, mucosal laceration is likely underreported as second-look endoscopy is not always performed following Savary or Maloney dilation. With mucosal tears of the oesophageal mucosa, post-procedural chest pain may develop. This is also most likely an underreported finding that patients may not seek medical attention for pain and endoscopists may not follow-up with patients within the days after dilation.
Among the studies included, 9% of patients experienced chest pain, however less than 1% required hospitalisation for pain management.
The only study to demonstrate a discrepancy between chest pain found in patient records versus in a post-procedural survey was by Schoepfer et al. 21 While medical records documented chest pain in only 7% of cases, in actuality, it occurred in 74% of patients, albeit mild. In most cases, this pain is self-limited, and can be managed with topical analgesics.
In our review, two cases were dilated with EndoFLIP, which has shown that reduced oesophageal distensibility can increase risk of food impaction, regardless of eosinophilic inflammation, 63 EndoFLIP may accurately identify patients with recurrent food impaction or dysphagia and therefore may identify candidates for oesophageal dilation. Whether the addition of this tool will enhance our understanding of dysphagia in EoE and refine our indications for endoscopic dilation remains to be elucidated.
Last, one of our aims was to explore whether factors can predict improvement in symptoms. Some studies reported a target oesophageal diameter following dilation, however, the data were not sufficient to obtain a summary estimate. We also wanted to compare the safety and efficacy of the three types of dilators, but given the limited number of studies with very low number of events, we could not perform meta-regression.
Our meta-analysis has several strengths. We performed a comprehensive search strategy of all major databases, as well as, F I G U R E 3 Forest plot for the frequency of the four major complications with dilation abstracts from major meetings, without any restriction to language.
Professional librarians with experience in meta-analysis assisted us in our search strategy. All studies were screened by two teams in duplicate and data abstraction was performed in duplicate as well to minimise bias. Our review included children and adults therefore making our results more generalisable to all EoE patients.
The major limitation of our review was the quality of evidence included. There was only one small randomised controlled trial and two prospective cohorts. The majority of studies were retrospective and case reports, therefore, we were not able to grade the quality of studies included. This is particularly a limitation when attempting to assess clinical effectiveness of a procedure. The duration of followup after dilation was not reported in all studies and was limited to a relatively short period of time. We aimed to explore difference in types of dilators in complications and response, however, due to the limited number of studies with a low number of events, we could not compare differences.
In summary, oesophageal dilation is highly effective in improving clinical symptoms, at least in the short term, and is a safe procedure with a very low major complication rate.
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